$2.53T
Total marketcap
$189.93B
Total volume
BTC 50.01%     ETH 15.90%
Dominance

Aurinia Pharmaceuticals AUPH Stock

5.09 USD {{ price }} -1.547387% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
736.11M USD
LOW - HIGH [24H]
5.06 - 5.22 USD
VOLUME [24H]
1.23M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.54 USD

Aurinia Pharmaceuticals Price Chart

Aurinia Pharmaceuticals AUPH Financial and Trading Overview

Aurinia Pharmaceuticals stock price 5.09 USD
Previous Close 9.86 USD
Open 9.85 USD
Bid 0 USD x 800
Ask 0 USD x 2200
Day's Range 9.63 - 10 USD
52 Week Range 4.07 - 12.6 USD
Volume 1.11M USD
Avg. Volume 2.84M USD
Market Cap 1.42B USD
Beta (5Y Monthly) 1.182746
PE Ratio (TTM) N/A
EPS (TTM) -0.54 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 16 USD

AUPH Valuation Measures

Enterprise Value 1.07B USD
Trailing P/E N/A
Forward P/E -23.642859
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 9.674335
Price/Book (mrq) 3.6373627
Enterprise Value/Revenue 7.29
Enterprise Value/EBITDA -10.646

Trading Information

Aurinia Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.182746
52-Week Change -6.58%
S&P500 52-Week Change 20.43%
52 Week High 12.6 USD
52 Week Low 4.07 USD
50-Day Moving Average 10.59 USD
200-Day Moving Average 8.15 USD

AUPH Share Statistics

Avg. Volume (3 month) 2.84M USD
Avg. Daily Volume (10-Days) 1.7M USD
Shares Outstanding 143.03M
Float 140.04M
Short Ratio 5.83
% Held by Insiders 7.07%
% Held by Institutions 38.23%
Shares Short 16.7M
Short % of Float 11.72%
Short % of Shares Outstanding 11.67%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -65.90%
Operating Margin (ttm) -70.27%
Gross Margin 65.01%
EBITDA Margin -68.47%

Management Effectiveness

Return on Assets (ttm) -13.45%
Return on Equity (ttm) -23.077%

Income Statement

Revenue (ttm) 146.81M USD
Revenue Per Share (ttm) 1.03 USD
Quarterly Revenue Growth (yoy) 59.09%
Gross Profit (ttm) 83.38M USD
EBITDA -100530000 USD
Net Income Avi to Common (ttm) -96756000 USD
Diluted EPS (ttm) -0.66
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 360.86M USD
Total Cash Per Share (mrq) 2.52 USD
Total Debt (mrq) 7.93M USD
Total Debt/Equity (mrq) 2.03 USD
Current Ratio (mrq) 10.076
Book Value Per Share (mrq) 2.73

Cash Flow Statement

Operating Cash Flow (ttm) -64453000 USD
Levered Free Cash Flow (ttm) -22619500 USD

Profile of Aurinia Pharmaceuticals

Country United States
State BC
City Victoria
Address 4464 Markham Street
ZIP V8Z 7X8
Phone 250 708 4272
Website https://www.auriniapharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 300

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Q&A For Aurinia Pharmaceuticals Stock

What is a current AUPH stock price?

Aurinia Pharmaceuticals AUPH stock price today per share is 5.09 USD.

How to purchase Aurinia Pharmaceuticals stock?

You can buy AUPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Aurinia Pharmaceuticals?

The stock symbol or ticker of Aurinia Pharmaceuticals is AUPH.

Which industry does the Aurinia Pharmaceuticals company belong to?

The Aurinia Pharmaceuticals industry is Biotechnology.

How many shares does Aurinia Pharmaceuticals have in circulation?

The max supply of Aurinia Pharmaceuticals shares is 144.62M.

What is Aurinia Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Aurinia Pharmaceuticals PE Ratio is now.

What was Aurinia Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Aurinia Pharmaceuticals EPS is -0.54 USD over the trailing 12 months.

Which sector does the Aurinia Pharmaceuticals company belong to?

The Aurinia Pharmaceuticals sector is Healthcare.

Aurinia Pharmaceuticals AUPH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN 1704.47 GBP 2179.91 USD
0
1704.47 GBP 2179.91 USD 1704.47 GBP 2179.91 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD